Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exploratory Study of CS-3150 vs Olmesartan in Essential Hypertension
jRCT2080223269Phase 3Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of esaxerenone in essential hypertension (2 arms), sponsored by Daiichi Sankyo Co., Ltd. Started Jul 2016; status: completed.
02
Drugs
esaxerenone
03
Conditions
essential hypertension
Beyond the preview
Go deeper on jRCT2080223269.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223269.